Literature DB >> 12735129

Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease.

Reza Kianmanesh1, Jean Marc Regimbeau, Jacques Belghiti.   

Abstract

For large HCCs, partial liver resection remains the best therapeutic option for cure because neither liver transplantation nor percutaneous treatments are indicated. In specialized centers, a better selection of at-risk patients and technical procedures, including the use of intermittent inflow occlusion and the anterior approach, have contributed to improve dramatically the outcome of major liver resection for HCC in CLD. In addition, portal vein embolization has become an important tool to hypertrophy the future liver remnant before major liver resection in cirrhotic patients with apparently normal liver function.

Entities:  

Mesh:

Year:  2003        PMID: 12735129     DOI: 10.1016/s1055-3207(02)00090-x

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  21 in total

1.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

2.  Liver angulometry: a simple method to estimate liver volume and ratios.

Authors:  Reza Kianmanesh; Tullio Piardi; Esther Tamby; Alina Parvanescu; Onorina Bruno; Elisa Palladino; Olivier Bouché; Simon Msika; Daniele Sommacale
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

3.  Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study.

Authors:  Chi Leung Liu; Sheung Tat Fan; Siu Tim Cheung; Chung Mau Lo; Irene O Ng; John Wong
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 4.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Abhijeet Waghray; Arvind R Murali; Kv Narayanan Menon
Journal:  World J Hepatol       Date:  2015-05-18

5.  Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.

Authors:  Toshifumi Hoki; Eriko Katsuta; Li Yan; Kazuaki Takabe; Fumito Ito
Journal:  J Surg Res       Date:  2019-02       Impact factor: 2.192

6.  Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.

Authors:  Guangcong Zhang; Xiangnan Yu; Peng Liu; Xiaoxi Huang; Xuemei Jiang
Journal:  Dig Dis Sci       Date:  2018-08-23       Impact factor: 3.199

Review 7.  Laparoscopic-assisted ablation of hepatic tumors: a review.

Authors:  Philip T Pepple; David A Gerber
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

8.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy.

Authors:  Hiroshi Shintani; Shoji Oura; Shinichiro Makimoto
Journal:  Case Rep Oncol       Date:  2021-06-04

10.  Hepatocellular carcinoma: natural history, current management, and emerging tools.

Authors:  Christopher L Tinkle; Daphne Haas-Kogan
Journal:  Biologics       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.